Pharmaxis Ltd.
Records under this name other than the patents Pharmaxis Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,220,164 | Delivery Devices Formerly held In force · High confidence | In force | High confidence | |
| US 10,786,637 | Delivery devices Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,795,748 | Delivery devices Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,717,733 | Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,717,734 | Indole and azaindole haloallylamine derivative inhibitors of lysyl oxidases and uses thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,098,045 | Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,178,791 | Haloallylamine Sulfone Derivative Inhibitors of Lysyl Oxidases and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 8,118,790 | Battery Operated Surgical Hand Piece with Disposable End Formerly held Lapsed on the fee record Ended Feb 21, 2024 · High confidence | Lapsed on the fee record | Ended Feb 21, 2024 | High confidence |
| US 7,745,420 | Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals Lapsed on the fee record Ended Jun 29, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jun 29, 2022 | From the USPTO record |
| US 6,822,087 | Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation Term ended Term ended Jun 29, 2021 · From the USPTO record | Term ended | Term ended Jun 29, 2021 | From the USPTO record |